| 1 | [SID103525989] | Active | IC50 | 0.005 | Inhibition of mouse 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay in presence of NADPH [AID352314, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:1706408] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.005 [uM] | | BioAssay | Inhibition of mouse 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay in presence of NADPH | | AID | 352314 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:1706408] | | PubMed | 18653260 | | Data Table |  |
|
| 2 | [SID103525989] | Active | IC50 | 0.0086 | Inhibition of human 11beta HSD1 expressed in HEK293 cells assessed as assessed as inhibition of [1,2-(n)3H]cortisone to [3H]-cortisol after 60 mins by scintillation proximity assay [AID621453, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.0086 [uM] | | BioAssay | Inhibition of human 11beta HSD1 expressed in HEK293 cells assessed as assessed as inhibition of [1,2-(n)3H]cortisone to [3H]-cortisol after 60 mins by scintillation proximity assay | | AID | 621453 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] | | PubMed | 21873057 | | Data Table |  |
|
| 3 | [SID103525989] | Active | IC50 | 0.0086 | Inhibition of human 11beta HSD1 expressed in HEK293 cells assessed as assessed as inhibition of [1,2-(n)3H]cortisone to [3H]-cortisol after 60 mins by scintillation proximity assay [AID621453, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.0086 [uM] | | BioAssay | Inhibition of human 11beta HSD1 expressed in HEK293 cells assessed as assessed as inhibition of [1,2-(n)3H]cortisone to [3H]-cortisol after 60 mins by scintillation proximity assay | | AID | 621453 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] | | PubMed | 21873057 | | Data Table |  |
|
| 4 | [SID103525989] | Active | IC50 | 0.01058 | Inhibition of mouse 11beta-HSD1 [AID316049, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:1706408] |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.01058 [uM] | | BioAssay | Inhibition of mouse 11beta-HSD1 | | AID | 316049 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:1706408] | | PubMed | 18242087 | | Data Table |  |
|
| 5 | [SID103525989] | Active | IC50 | 0.01178 | Inhibition of human 11beta-HSD1 [AID316048, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.01178 [uM] | | BioAssay | Inhibition of human 11beta-HSD1 | | AID | 316048 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] | | PubMed | 18242087 | | Data Table |  |
|
| 6 | [SID103525989] | Active | IC50 | 0.01178 | Inhibition of human 11beta-HSD1 [AID316048, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.01178 [uM] | | BioAssay | Inhibition of human 11beta-HSD1 | | AID | 316048 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] | | PubMed | 18242087 | | Data Table |  |
|
| 7 | [SID103525989] | Active | IC50 | 0.013 | Inhibition of human 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay in presence of NADPH [AID352313, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.013 [uM] | | BioAssay | Inhibition of human 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay in presence of NADPH | | AID | 352313 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] | | PubMed | 18653260 | | Data Table |  |
|
| 8 | [SID103525989] | Active | IC50 | 0.013 | Inhibition of human 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay in presence of NADPH [AID352313, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.013 [uM] | | BioAssay | Inhibition of human 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay in presence of NADPH | | AID | 352313 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] | | PubMed | 18653260 | | Data Table |  |
|
| 9 | [SID103525989] | Active | IC50 | 0.09 | Inhibition of 11beta-HSD1 in rat liver assessed as cortisone level [AID456093, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:23830928] |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.09 [uM] | | BioAssay | Inhibition of 11beta-HSD1 in rat liver assessed as cortisone level | | AID | 456093 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:23830928] | | PubMed | 19914836 | | Data Table |  |
|
| 10 | [SID103525989] | Active | IC50 | 0.09 | Inhibition of rat hepatic 11beta-HSD1 [AID587118, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:23830928] |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.09 [uM] | | BioAssay | Inhibition of rat hepatic 11beta-HSD1 | | AID | 587118 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:23830928] | | PubMed | 21376605 | | Data Table |  |
|
| 11 | [SID103525989] | Active | Kd | 0.25 | Binding affinity to recombinant human PKCeta in after 2 hrs by microequilibrium dialysis assay [AID605339, Type: Literature] | Protein kinase C eta type [gi:281185512] |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | Kd | 0.25 [uM] | | BioAssay | Binding affinity to recombinant human PKCeta in after 2 hrs by microequilibrium dialysis assay | | AID | 605339 | | BioAssay type | Literature | | Target | Protein kinase C eta type [gi:281185512] | | PubMed | 20836515 | | Data Table |  |
|
| 12 | [SID103525989] | Active | Kd | 0.25 | Binding affinity to recombinant human PKCeta in after 2 hrs by microequilibrium dialysis assay [AID605339, Type: Literature] | Protein kinase C eta type [gi:281185512] |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | Kd | 0.25 [uM] | | BioAssay | Binding affinity to recombinant human PKCeta in after 2 hrs by microequilibrium dialysis assay | | AID | 605339 | | BioAssay type | Literature | | Target | Protein kinase C eta type [gi:281185512] | | PubMed | 20836515 | | Data Table |  |
|
| 13 | [SID103525989] | Active | IC50 | 0.257 | Inhibition of human recombinant 11beta-HSD2 expressed in HEK293 cells assessed as conversion of [1,2,6,7-3H]-cortisol to cortisone by scintillation counting [AID526982, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 2 [gi:30316367] |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.257 [uM] | | BioAssay | Inhibition of human recombinant 11beta-HSD2 expressed in HEK293 cells assessed as conversion of [1,2,6,7-3H]-cortisol to cortisone by scintillation counting | | AID | 526982 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 2 [gi:30316367] | | PubMed | 20851614 | | Data Table |  |
|
| 14 | [SID103525989] | Active | IC50 | 0.257 | Inhibition of human 11beta-HSD2 expressed in HEK293 cells assessed as conversion of [1,2,6,7-[3H]cortisol to cortisone after 10 mins by scintillation counting [AID587116, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 2 [gi:30316367] |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.257 [uM] | | BioAssay | Inhibition of human 11beta-HSD2 expressed in HEK293 cells assessed as conversion of [1,2,6,7-[3H]cortisol to cortisone after 10 mins by scintillation counting | | AID | 587116 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 2 [gi:30316367] | | PubMed | 21376605 | | Data Table |  |
|
| 15 | [SID103525989] | Active | IC50 | 0.36 | Inhibition of rat renal 11beta-HSD2 in rat liver assessed as inhibition of cortisone production [AID456094, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 2 [gi:1706412] |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.36 [uM] | | BioAssay | Inhibition of rat renal 11beta-HSD2 in rat liver assessed as inhibition of cortisone production | | AID | 456094 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 2 [gi:1706412] | | PubMed | 19914836 | | Data Table |  |
|
| 16 | [SID103525989] | Active | IC50 | 0.36 | Inhibition of rat renal 11beta-HSD2 [AID587119, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 2 [gi:1706412] |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.36 [uM] | | BioAssay | Inhibition of rat renal 11beta-HSD2 | | AID | 587119 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 2 [gi:1706412] | | PubMed | 21376605 | | Data Table |  |
|
| 17 | [SID103525989] | Active | IC50 | 0.778 | Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [1,2-3H]-cortisone to cortisol by scintillation counting [AID526983, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.778 [uM] | | BioAssay | Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [1,2-3H]-cortisone to cortisol by scintillation counting | | AID | 526983 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] | | PubMed | 20851614 | | Data Table |  |
|
| 18 | [SID103525989] | Active | IC50 | 0.778 | Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [1,2-[3H]cortisone to cortisol after 10 mins by scintillation counting [AID587113, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.778 [uM] | | BioAssay | Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [1,2-[3H]cortisone to cortisol after 10 mins by scintillation counting | | AID | 587113 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] | | PubMed | 21376605 | | Data Table |  |
|
| 19 | [SID103525989] | Active | IC50 | 0.778 | Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [1,2-3H]-cortisone to cortisol by scintillation counting [AID526983, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.778 [uM] | | BioAssay | Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [1,2-3H]-cortisone to cortisol by scintillation counting | | AID | 526983 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] | | PubMed | 20851614 | | Data Table |  |
|
| 20 | [SID103525989] | Active | IC50 | 0.778 | Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [1,2-[3H]cortisone to cortisol after 10 mins by scintillation counting [AID587113, Type: Literature] | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 0.778 [uM] | | BioAssay | Inhibition of human recombinant 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [1,2-[3H]cortisone to cortisol after 10 mins by scintillation counting | | AID | 587113 | | BioAssay type | Literature | | Target | Corticosteroid 11-beta-dehydrogenase isozyme 1 [gi:118569] | | PubMed | 21376605 | | Data Table |  |
|
| 21 | [SID103525989] | Active | IC50 | 1.3 | Inhibition of LPS-induced TNFalpha release in mouse RAW264.7 cells pretreated 1 hr before LPS challenge by enyme immunoassay [AID418484, Type: Literature] | |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 1.3 [uM] | | BioAssay | Inhibition of LPS-induced TNFalpha release in mouse RAW264.7 cells pretreated 1 hr before LPS challenge by enyme immunoassay | | AID | 418484 | | BioAssay type | Literature | | Target | | | PubMed | 19278854 | | Data Table |  |
|
| 22 | [SID144204355] | Active | Potency | 2.3715 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 144204355 | | CID | 10114 | | Outcome | Active | | Potency | 2.3715 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID103525989] | Active | IC50 | 7.3 | Antiproliferative activity against mouse r/m HM-SFME-1 cells after 24 hrs by MTT assay [AID490287, Type: Literature] | |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 7.3 [uM] | | BioAssay | Antiproliferative activity against mouse r/m HM-SFME-1 cells after 24 hrs by MTT assay | | AID | 490287 | | BioAssay type | Literature | | Target | | | PubMed | 20398972 | | Data Table |  |
|
| 24 | [SID144204355] | Active | Potency | 7.4993 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 144204355 | | CID | 10114 | | Outcome | Active | | Potency | 7.4993 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID104171338] | Active | Potency | 8.0875 | S16 Schwann cell PMP22 intronic element firefly luciferase assay [AID624032, Type: confirmatory] | Pmp22 gene product [Rattus norvegicus] [gi:8393992] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 104171338 | | CID | 10114 | | Outcome | Active | | Potency | 8.0875 [uM] | | BioAssay | S16 Schwann cell PMP22 intronic element firefly luciferase assay | | AID | 624032 | | BioAssay type | confirmatory | | Target | Pmp22 gene product [Rattus norvegicus] [gi:8393992] | | PubMed | | | Data Table |  |
|
| 26 | [SID103525989] | Active | IC50 | 9.6 | Inhibition of recombinant SHP2 [AID551432, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 9.6 [uM] | | BioAssay | Inhibition of recombinant SHP2 | | AID | 551432 | | BioAssay type | Literature | | Target | | | PubMed | 21193311 | | Data Table |  |
|
| 27 | [SID103525989] | Active | EC50 | 16 | Reduction in surface tension in 0.1 M PBS after 10 mins by Wilhelmy plate method using tensitometer [AID658065, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | EC50 | 16 [uM] | | BioAssay | Reduction in surface tension in 0.1 M PBS after 10 mins by Wilhelmy plate method using tensitometer | | AID | 658065 | | BioAssay type | Literature | | Target | | | PubMed | 22503361 | | Data Table |  |
|
| 28 | [SID103525989] | Active | IC50 | 18 | Antiproliferative activity against mouse SFME cells after 24 hrs by MTT assay [AID490286, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 18 [uM] | | BioAssay | Antiproliferative activity against mouse SFME cells after 24 hrs by MTT assay | | AID | 490286 | | BioAssay type | Literature | | Target | | | PubMed | 20398972 | | Data Table |  |
|
| 29 | [SID103525989] | Active | IC50 | 18.52 | Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay [AID528069, Type: Literature] | |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 18.52 [uM] | | BioAssay | Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay | | AID | 528069 | | BioAssay type | Literature | | Target | | | PubMed | 20932766 | | Data Table |  |
|
| 30 | [SID103525989] | Active | ED50 | 19.5 | Cytotoxicity against human HCT8 cells [AID300499, Type: Literature] | |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | ED50 | 19.5 [uM] | | BioAssay | Cytotoxicity against human HCT8 cells | | AID | 300499 | | BioAssay type | Literature | | Target | | | PubMed | 17591444 | | Data Table |  |
|
| 31 | [SID103525989] | Active | IC50 | 20.86 | Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release [AID659364, Type: Literature] | |   View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 20.86 [uM] | | BioAssay | Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in hepatitis B surface antigen release | | AID | 659364 | | BioAssay type | Literature | | Target | | | PubMed | 22520261 | | Data Table |  |
|
| 32 | [SID103525989] | Active | IC50 | 22.3 | Inhibition of chymotrypsin-like activity of human 20S proteasome [AID343737, Type: Literature] | |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 22.3 [uM] | | BioAssay | Inhibition of chymotrypsin-like activity of human 20S proteasome | | AID | 343737 | | BioAssay type | Literature | | Target | | | PubMed | 18562200 | | Data Table |  |
|
| 33 | [SID103525989] | Active | IC50 | 27.31 | Cytotoxicity against human NTUB1 cells after 72 hrs by MTT assay [AID608127, Type: Literature] | |   View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 27.31 [uM] | | BioAssay | Cytotoxicity against human NTUB1 cells after 72 hrs by MTT assay | | AID | 608127 | | BioAssay type | Literature | | Target | | | PubMed | 21696969 | | Data Table |  |
|
| 34 | [SID104171338] | Active | Potency | 33.5875 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 104171338 | | CID | 10114 | | Outcome | Active | | Potency | 33.5875 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 35 | [SID104171338] | Active | Potency | 33.5875 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 104171338 | | CID | 10114 | | Outcome | Active | | Potency | 33.5875 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 36 | [SID103525989] | Active | GI50 | 37 | Growth inhibition in mouse B16F10 after 3 days by MTT assay [AID623268, Type: Literature] | |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | GI50 | 37 [uM] | | BioAssay | Growth inhibition in mouse B16F10 after 3 days by MTT assay | | AID | 623268 | | BioAssay type | Literature | | Target | | | PubMed | 21888390 | | Data Table |  |
|
| 37 | [SID103525989] | Active | IC50 | 39.28 | Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication [AID659368, Type: Literature] | |   View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 39.28 [uM] | | BioAssay | Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA replication | | AID | 659368 | | BioAssay type | Literature | | Target | | | PubMed | 22520261 | | Data Table |  |
|
| 38 | [SID103525989] | Active | IC50 | 45.8 | Inhibition of recombinant PTP1B [AID551434, Type: Literature] | |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | IC50 | 45.8 [uM] | | BioAssay | Inhibition of recombinant PTP1B | | AID | 551434 | | BioAssay type | Literature | | Target | | | PubMed | 21193311 | | Data Table |  |
|
| 39 | [SID103525989] | Active | | | Drug uptake in human HeLa cells assessed as subcellular localization in endoplasmic reticulum at 25 uM after 6 hrs by live cell microscopic analysis [AID605337, Type: Literature] | |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | BioAssay | Drug uptake in human HeLa cells assessed as subcellular localization in endoplasmic reticulum at 25 uM after 6 hrs by live cell microscopic analysis | | AID | 605337 | | BioAssay type | Literature | | Target | | | PubMed | 20836515 | | Data Table |  |
|
| 40 | [SID103525989] | Active | | | Cytostatic activity against human U373 cells assessed as absence of induction of apoptosis at 80 uM after 48 to 72 hrs by TUNEL-based flow cytometric analysis [AID623273, Type: Literature] | |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | BioAssay | Cytostatic activity against human U373 cells assessed as absence of induction of apoptosis at 80 uM after 48 to 72 hrs by TUNEL-based flow cytometric analysis | | AID | 623273 | | BioAssay type | Literature | | Target | | | PubMed | 21888390 | | Data Table |  |
|
| 41 | [SID103525989] | Active | | | Cytostatic activity against human A549 cells assessed as absence of induction of apoptosis at 100 uM after 48 to 72 hrs by TUNEL-based flow cytometric analysis [AID623274, Type: Literature] | |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | BioAssay | Cytostatic activity against human A549 cells assessed as absence of induction of apoptosis at 100 uM after 48 to 72 hrs by TUNEL-based flow cytometric analysis | | AID | 623274 | | BioAssay type | Literature | | Target | | | PubMed | 21888390 | | Data Table |  |
|
| 42 | [SID103525989] | Active | | | Metabolic stability in human liver microsomes assessed as GSH adduct formation at 100 uM after 90 mins by HPLC-MS analysis [AID678721, Type: Literature] | |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | BioAssay | Metabolic stability in human liver microsomes assessed as GSH adduct formation at 100 uM after 90 mins by HPLC-MS analysis | | AID | 678721 | | BioAssay type | Literature | | Target | | | PubMed | 22931300 | | Data Table |  |
|
| 43 | [SID103525989] | Active | | | Inhibition of human CYP2C9 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-methoxy-4-trifluoromethylcoumarin-3-acetic acid as substrate after 30 mins [AID678713, Type: Literature] | |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | BioAssay | Inhibition of human CYP2C9 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-methoxy-4-trifluoromethylcoumarin-3-acetic acid as substrate after 30 mins | | AID | 678713 | | BioAssay type | Literature | | Target | | | PubMed | 22931300 | | Data Table |  |
|
| 44 | [SID103525989] | Active | | | Inhibition of human CYP2C19 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 3-butyryl-7-methoxycoumarin as substrate after 30 mins [AID678714, Type: Literature] | |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | BioAssay | Inhibition of human CYP2C19 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 3-butyryl-7-methoxycoumarin as substrate after 30 mins | | AID | 678714 | | BioAssay type | Literature | | Target | | | PubMed | 22931300 | | Data Table |  |
|
| 45 | [SID103525989] | Active | | | Inhibition of human CYP2D6 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 4-methylaminoethyl-7-methoxycoumarin as substrate after 30 mins [AID678715, Type: Literature] | |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | BioAssay | Inhibition of human CYP2D6 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 4-methylaminoethyl-7-methoxycoumarin as substrate after 30 mins | | AID | 678715 | | BioAssay type | Literature | | Target | | | PubMed | 22931300 | | Data Table |  |
|
| 46 | [SID103525989] | Active | | | Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using diethoxyfluorescein as substrate after 30 mins [AID678716, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | BioAssay | Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using diethoxyfluorescein as substrate after 30 mins | | AID | 678716 | | BioAssay type | Literature | | Target | | | PubMed | 22931300 | | Data Table |  |
|
| 47 | [SID103525989] | Active | | | Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-benzyloxyquinoline as substrate after 30 mins [AID678717, Type: Literature] | |   View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | BioAssay | Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-benzyloxyquinoline as substrate after 30 mins | | AID | 678717 | | BioAssay type | Literature | | Target | | | PubMed | 22931300 | | Data Table |  |
|
| 48 | [SID103525989] | Active | | | Activation of caspase-like activity of 20S proteasome in human U373 cells at 90 uM after 2 days by bioluminescence assay [AID622024, Type: Literature] | |   View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | BioAssay | Activation of caspase-like activity of 20S proteasome in human U373 cells at 90 uM after 2 days by bioluminescence assay | | AID | 622024 | | BioAssay type | Literature | | Target | | | PubMed | 21888390 | | Data Table |  |
|
| 49 | [SID103525989] | Active | | | Activation of chymotrypsin-like activity of 20S proteasome in human U373 cells at 90 uM after 2 days by bioluminescence assay [AID621960, Type: Literature] | |   View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | BioAssay | Activation of chymotrypsin-like activity of 20S proteasome in human U373 cells at 90 uM after 2 days by bioluminescence assay | | AID | 621960 | | BioAssay type | Literature | | Target | | | PubMed | 21888390 | | Data Table |  |
|
| 50 | [SID103525989] | Active | | | Inhibition of trypsin-like activity of 20S proteasome in human U373 cells at 90 uM after 2 days by bioluminescence assay [AID621961, Type: Literature] | |   View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103525989 | | CID | 10114 | | Outcome | Active | | BioAssay | Inhibition of trypsin-like activity of 20S proteasome in human U373 cells at 90 uM after 2 days by bioluminescence assay | | AID | 621961 | | BioAssay type | Literature | | Target | | | PubMed | 21888390 | | Data Table |  |
|